These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6374069)

  • 21. Paraplegia following chymopapain injection. A case report.
    Brown MD
    J Bone Joint Surg Am; 1985 Mar; 67(3):504. PubMed ID: 3882719
    [No Abstract]   [Full Text] [Related]  

  • 22. Transverse myelitis following chemonucleolysis.
    J Bone Joint Surg Am; 1985 Feb; 67(2):345-6. PubMed ID: 3881451
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allergy to chymopapain: value of predictive tests before chemonucleolysis].
    Moneret-Vautrin DA; Benoist M; Laxenaire MC; Croizier A; Guéant JL
    Ann Fr Anesth Reanim; 1985; 4(3):313-5. PubMed ID: 3893237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intervertebral disc disease treatment by chymopapain injection and open surgery.
    Watts C; Hutchison G; Stern J; Clark K
    J Neurosurg; 1975 Apr; 42(4):397-400. PubMed ID: 1123657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemonucleolysis. The treatment of lumbar intervertebral disc disease by the intradiscal injection of chymopapain.
    Watts C; Gaines R
    Mo Med; 1983 Dec; 80(12):735-7, 742. PubMed ID: 6371477
    [No Abstract]   [Full Text] [Related]  

  • 26. Late results of treatment of intervertebral disc disease with chymopapain.
    Parkinson D
    J Neurosurg; 1983 Dec; 59(6):990-3. PubMed ID: 6355406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of chymopapain chemonucleolysis. A long-term review of 105 patients.
    Javid MJ
    J Neurosurg; 1985 May; 62(5):662-6. PubMed ID: 3886850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term results of chymopapain chemonucleolysis for lumbar disc disease. Ten-year follow-up results in 268 patients injected at the Mayo Clinic.
    Maciunas RJ; Onofrio BM
    J Neurosurg; 1986 Jul; 65(1):1-8. PubMed ID: 3712015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anesthesiologic aspects of chemonucleolysis in local anesthesia].
    Schäffer J; Piepenbrock S; Mayer HM; Brock M
    Anasth Intensivther Notfallmed; 1985 Apr; 20(2):62-4. PubMed ID: 2990249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse reactions to chemonucleolysis: anesthetic considerations.
    Moss J; Roizen MF
    Int Anesthesiol Clin; 1985; 23(3):119-32. PubMed ID: 2863221
    [No Abstract]   [Full Text] [Related]  

  • 31. Sudden hypotension with a test dose of chymopapain.
    Bruno LA; Smith DS; Bloom MJ; Domino K; Bagshaw RJ; Star AM; Cohen AM; Lupo SE
    Anesth Analg; 1984 May; 63(5):533-5. PubMed ID: 6370040
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaphylactic reactions following intradiscal injection of chymopapain under local anesthesia.
    Jacobs DM; Lipton MH; Russell SM
    J Bone Joint Surg Am; 1984 Jun; 66(5):806-7. PubMed ID: 6373775
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity reactions to intradiscal injection of chymopapain during general anesthesia.
    Watts C; Williams OB; Goldstein G
    Anesthesiology; 1976 May; 44(5):437-9. PubMed ID: 1267213
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
    Grammer LC; Schafer M; Bernstein D; Bernstein IL; Dolovich J; Schatz M; Zeiger R; Cogen F; Shaughnessy JJ; Chandler MJ
    Clin Orthop Relat Res; 1987 Aug; (221):202-6. PubMed ID: 3608299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chymopapain treatment of intervertebral disc disease.
    Watts C; Knighton R; Roulhac G
    J Neurosurg; 1975 Apr; 42(4):374-83. PubMed ID: 123575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis.
    Moss J
    Ann Fr Anesth Reanim; 1985; 4(2):221-4. PubMed ID: 2860828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chymodiactin postmarketing surveillance. Demographic and adverse experience data in 29,075 patients.
    Agre K; Wilson RR; Brim M; McDermott DJ
    Spine (Phila Pa 1976); 1984; 9(5):479-85. PubMed ID: 6387953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraplegia following chemonucleolysis. A case report and discussion of neurotoxicity.
    Dyck P
    Spine (Phila Pa 1976); 1985 May; 10(4):359-62. PubMed ID: 2931832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amicrobic spondylodiscitis following nucleolysis].
    Levernieux J
    Rev Rhum Mal Osteoartic; 1982; 49(8-9):659-61. PubMed ID: 6764852
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sensitization to chymopapain in patients treated with chemonucleolysis].
    García-Ortega P; Ramírez Ferreiras W; Sancho A; Urías S; Cisteró A
    Med Clin (Barc); 1991 Mar; 96(11):410-2. PubMed ID: 2046428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.